UK lawmakers form committee to promote life sciences sector

28 February 2020

In the UK, a group of lawmakers from different parties have come together to form a committee for raising political awareness of issues affecting the life sciences industry.

The All-Party Parliamentary Group (APPG) for Life Sciences will be chaired by Member of Parliament Daniel Zeichner, and will explore the challenges and opportunities facing the sector.

Mr Zeichner said: “I am delighted to continue as Chair of this APPG which will have a key role in highlighting to parliamentarians the valuable contribution our world-leading life sciences sector makes to the nation’s health and wealth."

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK